According to the projections, the burden of female breast cancer in India in 2025 is expected to be 5.6 million DALYs. Premature deaths due to breast cancer (YLLs) would contribute 5.3 million DALYs to the total burden, with the remaining due to disability (YLDs).
Policy and governance play crucial roles in addressing the rise in breast cancer among young people. Governments and healthcare institutions must prioritize comprehensive policies aimed at promoting awareness, prevention, and early detection programs. These policies should encompass educational campaigns targeting both the general population and healthcare professionals to enhance understanding of risk factors, symptoms, and screening protocols.
Speaking on holistic approaches on health and wellness of women in TOI's 'Right To Excellence,' Urvashi Prasad said " Undoubtedly, a lot of the programmes have focused on the health of women as it relates to their child bearing and child rearing roles, which points to wider societal issue. Now we are trying to make the conscious shift away from that and look at women's health and well being much holistically ."
The newly introduced Cancer Insurance Policy is specifically designed to provide financial security to women facing the daunting challenges of cancer diagnosis and treatment. With coverage extending to the five major types of cancer affecting women—breast, cervical, ovarian, oral, and colorectal cancer; the policies will provide lump-sum pay-outs upon diagnosis of any of the covered cancers, offering financial assistance ranging from Rs 5, 00,000 to Rs 30, 00,000
Mammography is an effecA new breast imaging technique detects cancer with high sensitivity while significantly lowering the likelihood of false-positive results, according to a study published today in Radiology: Imaging Cancer, a journal of the Radiological Society of North America.tive screening method for early detection of breast cancer; however, its sensitivity is reduced in dense tissue due to the masking effect of dense fibroglandular tissue.
The overall pooled estimate of prevalence in TNBC in India was 25.04%, according to a study —Triple Negative Breast Cancer Prevalence in Indian Patients over a Decade. This therapy is given pre-surgery for chemical reduction and it's for a long duration.
One of the biggest challenges to the timely treatment of breast cancer is delayed diagnosis. Approximately 59 per cent women in India get diagnosed when the condition has already spread outside the breast to nearby lymph nodes while 11 per cent get diagnosed when the cancer has spread to more distant parts of the body such as lungs, liver, or bones.
COVID-19 vaccine maker BioNTech, which is renewing its focus on its traditional roots in oncology, said in a joint statement with China's Duality that their drug would be tested on women with a certain type of advanced breast cancer with low levels of a cell surface receptor known as HER2.
The study, which was published in 'Cancer', an interdisciplinary journal of the American Cancer Society, was conducted among 17,331 patients who had breast cancer diagnosed between 2012 and 2015 from 11 Population-Based Cancer Registries (PBCRs) in India.
DISH, a FDA-approved technique is a gamechanger in accurate HER2 testing, crucial for precision therapy in breast cancer; significantly reducing the waiting period and subsequent delay in embarking on the right treatment plan.
The initiative is focussed on advancements in HER2 testing standardisation and reporting. As per the partnership, comprehensive training initiatives for pathologists and medical oncologists will be imparted. Training modules designed for oncologists will cover advances in HER-2 testing and HER-2 low interpretations.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
